The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
MPN Advances Day 2019 | What to look out for at ASH: focus on MPNs
Ruben Mesa
• 15 Nov 2019
Ruben Mesa, MD, FACP, Mays Cancer Center, UT Health San Antonio MD Anderson Cancer Center, discusses what myeloproliferative neoplams (MPNs) data to watch out for at the American Society of Hematology (ASH) Annual Meeting and Exposition 2019. This interview took place at the MPN Advances Day 2019 in London, UK.
